Indications & Dose:
Anorexia, cachexia, or unexplained weight loss in patients with AIDS (suspension); advanced breast or endometrial cancer
DOSE
Breast cancer: 160mg/day (40mg qid).
Endometrial cancer: 40mg/day to 320mg/day in divided doses.
• Anorexia, cachexia: PO 800 mg/day (20 ml susp/ day) initially; daily doses of 400-800 mg have been shown to be effective. At least 2 months of continuous treatment is considered an adequate period for determining efficacy.
Overdose: No serious side-effects resulted from studies involving administration as high as 800 mg/ day.
Contraindications:
As a diagnostic test for pregnancy, known or suspected pregnancy, prophylactic use to avoid weight loss
Warnings: Use in other types of neoplastic disease not recommended. Use of progestational agents during first 4 months of pregnancy is contraindicated.
Side Effects:
CNS: Headache, confusion, depression. hypesthesia, neuropathy, paresthesia
CV: Edema, palpitation
GI: Abdominal pain, nausea, vomiting, weight gain, flatulence
GU: Gynecomastia, breast tenderness, impotence, breakthrough bleeding
HEME: Thrombophlebitis, pulmonary embolism
RESP: Dyspnea
Cautions:
Precautions:
Children, HIV infected women
Interaction:
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team